acyclovir

Product NDC
71335-1381
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
acyclovir
Dosage form
TABLET
Route
ORAL
Labeler
Bryant Ranch Prepack
Application
ANDA077309
Marketing category
ANDA
Substance
ACYCLOVIR
Current FDA listing
Yes

Related Records

Packages

Package NDCDescriptionMarketing startMarketing endSampleStatus
71335-1381-0500 TABLET in 1 BOTTLE (71335-1381-0) 2024-07-092026-12-31NoHistorical
71335-1381-125 TABLET in 1 BOTTLE (71335-1381-1) 2024-07-092026-12-31NoHistorical
71335-1381-235 TABLET in 1 BOTTLE (71335-1381-2) 2019-10-312026-12-31NoHistorical
71335-1381-330 TABLET in 1 BOTTLE (71335-1381-3) 2019-10-282026-12-31NoHistorical
71335-1381-460 TABLET in 1 BOTTLE (71335-1381-4) 2024-07-092026-12-31NoHistorical
71335-1381-550 TABLET in 1 BOTTLE (71335-1381-5) 2024-07-092026-12-31NoHistorical
71335-1381-610 TABLET in 1 BOTTLE (71335-1381-6) 2024-07-092026-12-31NoHistorical
71335-1381-740 TABLET in 1 BOTTLE (71335-1381-7) 2024-07-092026-12-31NoHistorical
71335-1381-821 TABLET in 1 BOTTLE (71335-1381-8) 2020-05-192026-12-31NoHistorical
71335-1381-990 TABLET in 1 BOTTLE (71335-1381-9) 2024-07-092026-12-31NoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
ACYCLOVIR TABLETS, USP 400 mg and 800 mgBryant Ranch Prepack2024-07-09HUMAN PRESCRIPTION DRUG LABEL3